NCT06919887
A Randomized Controlled Trial of Menopausal Tool/App for Women
Enrolling by Invitation
NAAges 24–80InterventionalSupportive careMayo ClinicInvestigator-initiated
~900 participants
Updated 2026-06-16 on ClinicalTrials.gov
What's tested:EMMIIComparison Group
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Frequency of app logins among intervention group.
Measured over Up to 6 weeks
+3 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Women between the ages of 45 and 55
English speaking (app only available in English)
Able to provide informed consent
Experiencing menopause symptoms, which will be assessed by a Menopause Rating Scale (MRS) survey score of ≥ 5
Has an upcoming Mayo Clinic primary care appointment within 3 weeks of the enrollment and the MRS survey
Exclusion
Lack of willingness to engage with app
Inability to provide informed consent
What this trial measures
- Frequency of app logins among intervention group.Up to 6 weeks
- Compare differences in rates of menopause treatment among intervention and comparison groups.Up to 6 weeks
- Mean score on a validated survey assessing perceived importance and availability of healthcare services for women's health conditions/concerns related to menopausethrough study completion, an average of 1 year
- Percentage of healthcare professionals reporting 'high' & 'low' confidence in diagnosing and managing menopause symptomsthrough study completion, an average of 1 year